Get in touch

Submit

Thank you

 

A key aim of the patent system is to discourage inventors and innovative organisations from being secretive about their ideas and to stimulate creativity. A patent is essentially a bargain between the state and the innovator, to encourage them to disclose their work publicly so that all can benefit from and build upon technological progress. Without such incentives, innovation might take place covertly, behind a barrier of trade secrecy, or even not at all. It is easier to copy than to innovate, so patents afford protection for investors in innovation and ensure they can benefit commercially for the limited time period the patent covers.

 

In most major jurisdictions patents are assessed by technically skilled examiners appointed by national patent offices. These examiners have specialist subject knowledge and determine whether the invention that is described in the patent application and set out in statements called claims, meets the legal criteria for patentability. These criteria can vary slightly between countries but broadly they require a patentable invention to be new and non-obvious and also described sufficiently enough in the application that it enables the skilled reader to repeat the invention. Once a patent is granted, the patent owner typically receives 20 years from the filing date to enjoy the exclusivity of their patented invention before it becomes available for wider use by the public.

 

The law and processes around applying and enforcing patents can be very complex. They are driven by fixed timelines, formal legal requirements and a blend of science, law and business. Keltie’s attorneys exist to advise you on how to best navigate the system to get the best breadth of protection for your invention.

 

 

 

Image courtesy of MaximalFocus on Unsplash

MoreQ&A with Michael Moore: Leading innovations in biotechnology and intellectual property

19.06.2024

Q&A with Michael Moore: Leading innovations in biotechnology and intellectual property

Keltie features again in the Financial Times' prestigious list of Europe's Leading Patent Law Firms 2024. Keltie is one of the leading firms of IP specialists in Europe and is recognised by its peers across several core areas. We talk to Mike to discover what makes a successful IP firm and how biotechnology is evolving. He discusses his journey into the field and talks about all things ‘AI’.

MoreUPC Court of Appeal reverses Preliminary Injunction in first substantive decision

21.03.2024

UPC Court of Appeal reverses Preliminary Injunction in first substantive decision

The Court of Appeal of the Unified Patent Court (UPC) recently published its first decision considering substantive issues, in which it overturned a first instance decision of the Munich local division (NanoString (appellants) v 10x Genomics (respondents), UPC_CoA_335/2023).

Get in touch

Submit

Thank you